A delicate French dessert must rise perfectly under precise conditions. In biotechnology, Soufflé Therapeutics — a newly unveiled venture named after

Introduction The Variable Capital Company (VCC) represents a transformative development in Singapore's fund management landscape, particularly for healthcare

Introduction Special Purpose Vehicles (SPVs) play a pivotal role in the pharmaceutical and biotechnology sectors, facilitating innovative financing and structuring

Bankruptcy remoteness is a crucial concept in structuring financial deals — especially royalty financing transactions in the biotechnology and pharmaceutical industry.

The week saw concentrated M&A activity focused on MASH and neurological assets totalling over $10 billion in deal

The Allure of the "Up To" Deal Every so often, a biotech startup announces a blockbuster partnership with

Executive Summary CureDuchenne Ventures does not operate as a traditional venture capital firm. Instead, it represents a venture philanthropy model

Introduction Rome Therapeutics is a Boston-based biotechnology company on a mission to drug the "dark genome" – the vast

Introduction In recent months, several major biopharma companies have dramatically scaled back or outright halted their gene and cell therapy

Introduction Bristol Myers Squibb (BMS) and Takeda have recently joined forces with several peers in an ambitious data-sharing venture to